IFC sells its shareholding in Dabur Pharma

New Delhi, Aug 18 (UNI) Dabur Pharma Ltd today announced that International Finance Corporation (IFC), a private sector lending arm of the World Bank Group, has sold its entire stake of 12.14 million shares in the firm.

The company last week said its board had approved execution of a letter of intent (LoI) for an alliance with Fresenius Kabi AG, a unit of German health Care group Fresenius SE, for jointly developing business and providing global market access to Dabur's products.

Fresenius Kabi, which provides infusion therapy such as intra-venous drugs and clinical nutrition, said it will invest 30 million euros in the active pharmaceutical ingredient (API) plant of the company.

UNI SBA SP DS1301